What is PET/CT? - MedVision

PROSTATE CANCER diagnostics with 68Ga-PSMA

Diagnostic with 68Ga-PSMA allows to effectively discover metastatic prostate cancer and bone metastases, as well as to detect the relapsed prostate cancer location and stage.
Read more about prostate cancer diagnostics with 68Ga-PSMA.

PET/CT technology is advanced nuclear imaging technique that combines positron emission tomography (PET) and computed tomography (CT) into one machine.

  • The highly sensitive PET scan images the biology of disorders at the molecular level, while the CT scan provides a detailed picture of the body's internal anatomy.
  • By combining information about the body's metabolic function and anatomy, a PET/CT scan provides very detailed picture of cancerous tissues with high level of accuracy.
  • PET has a unique ability to assess the functional and biochemical processes of the body's tissues, which are altered in the earliest stage of disease. By identifying body changes at the cellular level, PET may detect the early onset of cancer generally before any anatomic changes are visible on ultrasound, X-ray, MRI, or CT scan.

    PET/CT scans provide valuable information to help physicians:

    • Locate the site of the cancer
    • Determine the size of the tumour
    • Effectively pinpoint the source of cancer
    • Differentiate benign from malignant growths
    • Discover if the cancer has spread
    • Select treatments that are likely to be appropriate
    • Monitor the success of therapy
    • Detect any recurrent tumours
    • Select an appropriate site for biopsy

    Which Oncological Diseases are Diagnosed with the PET/CT Most Often?
    The most frequently PET/CT is used for Hodgkin’s and non-Hodgkin lymphomas, breast cancer, colorectal and lung cancer, as well as prostate, uterine, cervical and ovarian cancer, stomach and esophageal cancer, pancreatic cancer, melanoma and sarcoma cases, as well as diagnosing the tumor of unknown location.